Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00010452

Locations


United States, California
	Children's Associated Medical Group
	San Diego, California, United States, 92123

United States, Colorado
	Children's Hospital of Denver
	Denver, Colorado, United States, 80218

United States, District of Columbia
	Childrens National Medical Center
	Washington, District of Columbia, United States

United States, Florida
	All Children's Hospital
	St. Petersburg, Florida, United States, 33701

United States, Iowa
	University of Iowa Hospitals and Clinics
	Iowa City, Iowa, United States, 52242

United States, Minnesota
	Children's Hospitals and Clinics - Minneapolis
	Minneapolis, Minnesota, United States, 55404

United States, New York
	SUNY Upstate Medical University
	Syracuse, New York, United States, 13210

United States, Oregon
	Oregon Health Sciences University
	Portland, Oregon, United States

United States, Tennessee
	Vanderbilt University
	Nashville, Tennessee, United States

United States, Texas
	Texas Pediatric Otolaryngology Center
	Houston, Texas, United States, 77030

United States, Virginia
	Children's Hospital of the Kings Daughter
	Norfolk, Virginia, United States, 23507

United States, Wisconsin
	Children's Hospital of Wisconsin
	Milwaukee, Wisconsin, United States, 53201
	University of Wisconsin Hospital and Clinics
	Madison, Wisconsin, United States, 53792-0001

Sponsors and Collaborators

University of Iowa

Chugai Pharmaceutical

Investigators


Study Chair:	Richard J Smith	University of Iowa